Home › Obstructive Lung Diseases
Obstructive Lung Diseases clinical trials recruiting in the U.S.
5 studies for Obstructive Lung Diseases are recruiting participants at sites across the United States.
By state
Recently updated studies
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Aug 11, 2026 · NCT07555483World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach (CaRVD)
RecruitingObservational study
Ages 21 to 90 · All sexes · Updated Feb 4, 2026 · NCT05215171BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jan 30, 2026 · NCT05341726Cough Capture as a Portal Into the Lung
RecruitingObservational study
Ages 21 and older · All sexes · Updated Jan 13, 2026 · NCT05854563A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.